{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:14:19Z","timestamp":1778202859737,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T00:00:00Z","timestamp":1572652800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s10620-019-05922-x","type":"journal-article","created":{"date-parts":[[2019,11,2]],"date-time":"2019-11-02T08:04:13Z","timestamp":1572681853000},"page":"3446-3450","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["It\u2019s What\u2019s Up Front That Counts\u2014Part Two: Esophageal Crohn\u2019s Disease Complicated by Recurrent Upper Gastrointestinal Bleeding"],"prefix":"10.1007","volume":"64","author":[{"given":"Alexander N.","family":"Levy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naiim","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Andrici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew J.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,2]]},"reference":[{"key":"5922_CR1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/00005176-200304000-00006","volume":"36","author":"K Ramaswamy","year":"2003","unstructured":"Ramaswamy K, Jacobson K, Jevon G, Israel D. Esophageal Crohn disease in children: a clinical spectrum. J Pediatr Gastroenterol Nutr. 2003;36:454\u2013458.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5922_CR2","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.83.5.777","volume":"83","author":"C Lenaerts","year":"1989","unstructured":"Lenaerts C, Roy CC, Vaillancourt M, Weber AM, Morin CL, Seidman E. High incidence of upper gastrointestinal tract involvement in children with Crohn disease. Pediatrics. 1989;83:777\u2013781.","journal-title":"Pediatrics"},{"key":"5922_CR3","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1097\/00005176-198905000-00004","volume":"8","author":"MN Mashako","year":"1989","unstructured":"Mashako MN, Cezard JP, Navarro J, et al. Crohn\u2019s disease lesions in the upper gastrointestinal tract: correlation between clinical, radiological, endoscopic, and histological features in adolescents and children. J Pediatr Gastroenterol Nutr. 1989;8:442\u2013446.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5922_CR4","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1097\/MIB.0000000000000469","volume":"21","author":"KM De Felice","year":"2015","unstructured":"De Felice KM, Katzka DA, Raffals LE. Crohn\u2019s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106\u20132113.","journal-title":"Inflamm Bowel Dis"},{"key":"5922_CR5","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/1477-7819-10-208","volume":"10","author":"W Wang","year":"2012","unstructured":"Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn\u2019s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.","journal-title":"World J Surg Oncol"},{"key":"5922_CR6","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.gie.2009.06.012","volume":"71","author":"BW Clarke","year":"2010","unstructured":"Clarke BW, Cassara JE, Morgan DR. Crohn\u2019s disease of the esophagus with esophagobronchial fistula formation: a case report and review of the literature. Gastrointest Endosc. 2010;71:207\u2013209.","journal-title":"Gastrointest Endosc"},{"key":"5922_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/00054725-200105000-00006","volume":"7","author":"GA Decker","year":"2001","unstructured":"Decker GA, Loftus EV, Pasha TM, Tremaine WJ, Sandborn WJ. Crohn\u2019s disease of the esophagus: clinical features and outcomes. Inflamm Bowel Dis. 2001;7:113\u2013119.","journal-title":"Inflamm Bowel Dis"},{"key":"5922_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/MPG.0b013e3181ec21b5","volume":"52","author":"RF Ammoury","year":"2011","unstructured":"Ammoury RF, Pfefferkorn MD. Significance of esophageal Crohn disease in children. J Pediatr Gastroenterol Nutr. 2011;52:291\u2013294.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"5922_CR9","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/02770900902777783","volume":"46","author":"MV Aun","year":"2009","unstructured":"Aun MV, Ribeiro MR, Costa Garcia CL, Agondi RC, Kalil J, Giavina-Bianchi P. Esophageal candidiasis\u2014an adverse effect of inhaled corticosteroids therapy. J Asthma. 2009;46:399\u2013401.","journal-title":"J Asthma"},{"key":"5922_CR10","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1111\/j.1572-0241.2003.07626.x","volume":"98","author":"N Kanda","year":"2003","unstructured":"Kanda N, Yasuba H, Takahashi T, et al. Prevalence of esophageal candidiasis among patients treated with inhaled fluticasone propionate. Am J Gastroenterol. 2003;98:2146\u20132148.","journal-title":"Am J Gastroenterol"},{"key":"5922_CR11","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/MIB.0000000000001266","volume":"23","author":"H Iskandar","year":"2017","unstructured":"Iskandar H, Greer JB, Krasinskas AM, et al. IBD live series-case 8: treatment options for refractory esophageal Crohn\u2019s disease and hidradenitis suppurativa. Inflamm Bowel Dis. 2017;23:1667\u20131677.","journal-title":"Inflamm Bowel Dis"},{"key":"5922_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/418769","volume":"2010","author":"Petros Zezos","year":"2010","unstructured":"Zezos P, Kouklakis G, Oikonomou A, Pitiakoudis M, Simopoulos C. Esophageal Crohn\u2019s disease treated \u2018topically\u2019 with swallowed aerosolized budesonide. Case Rep Med. 2010. https:\/\/doi.org\/10.1155\/2010\/418769 .","journal-title":"Case Reports in Medicine"},{"key":"5922_CR13","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","volume":"11","author":"F Gomoll\u00f3n","year":"2017","unstructured":"Gomoll\u00f3n F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn\u2019s disease 2016: part 1: diagnosis and medical management. J Crohns Colitis. 2017;11:3\u201325.","journal-title":"J Crohns Colitis"},{"key":"5922_CR14","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/S0016-5107(94)70059-1","volume":"40","author":"G D\u2019Haens","year":"1994","unstructured":"D\u2019Haens G, Rutgeerts P, Geboes K, Vantrappen G. The natural history of esophageal Crohn\u2019s disease: three patterns of evolution. Gastrointest Endosc. 1994;40:296\u2013300.","journal-title":"Gastrointest Endosc"},{"key":"5922_CR15","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11938-007-0058-3","volume":"10","author":"KL Isaacs","year":"2007","unstructured":"Isaacs KL. Crohn\u2019s disease of the esophagus. Curr Treat Options Gastroenterol. 2007;10:61\u201370.","journal-title":"Curr Treat Options Gastroenterol"},{"key":"5922_CR16","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00054725-199911000-00006","volume":"5","author":"T Heller","year":"1999","unstructured":"Heller T, James SP, Drachenberg C, Hernandez C, Darwin PE. Treatment of severe esophageal Crohn\u2019s disease with infliximab. Inflamm. Bowel Dis.. 1999;5:279\u2013282.","journal-title":"Inflamm. Bowel Dis."},{"key":"5922_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.crohns.2009.02.009","volume":"3","author":"R Grassia","year":"2009","unstructured":"Grassia R, Staiano T, Buffoli F, Paolo B. Severe esophageal Crohn\u2019s disease: healing of lesions after 1\u00a0week therapy with infliximab. J Crohns Colitis. 2009;3:138\u2013139.","journal-title":"J Crohns Colitis"},{"key":"5922_CR18","doi-asserted-by":"publisher","first-page":"107","DOI":"10.14309\/crj.2016.15","volume":"3","author":"JA Barkin","year":"2016","unstructured":"Barkin JA, Deshpande AR. Ustekinumab for successful treatment of refractory esophageal Crohn\u2019s disease. ACG Case Rep J. 2016;3:107\u2013108.","journal-title":"ACG Case Rep J"},{"key":"5922_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/ajg.2013.49","volume":"108","author":"JA Barkin","year":"2013","unstructured":"Barkin JA, Schonfeld WB, Deshpande AR. Successful use of thalidomide for refractory esophageal Crohn\u2019s disease. Am J Gastroenterol. 2013;108:855\u2013857.","journal-title":"Am J Gastroenterol"},{"key":"5922_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd007351.pub2","author":"AK Akobeng","year":"2009","unstructured":"Akobeng AK, Stokkers PC. Thalidomide and thalidomide analogues for maintenance of remission in Crohn\u2019s disease. Cochrane Database Syst. Rev. 2009;. https:\/\/doi.org\/10.1002\/14651858.cd007351.pub2 .","journal-title":"Cochrane Database Syst. Rev"},{"key":"5922_CR21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1046\/j.1440-1746.2002.02564.x","volume":"17","author":"C Bariol","year":"2002","unstructured":"Bariol C, Meagher AP, Vickers CR, et al. Early studies on the safety and efficacy of thalidomide for symptomatic inflammatory bowel disease. J Gastroenterol Hepatol. 2002;17:135\u2013139.","journal-title":"J Gastroenterol Hepatol"},{"key":"5922_CR22","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/SMJ.0b013e31818047be","volume":"101","author":"J Feagans","year":"2008","unstructured":"Feagans J, Victor D, Joshi V. Crohn disease of the esophagus: a review of the literature. South Med J. 2008;101:927\u2013930.","journal-title":"South Med J"},{"key":"5922_CR23","doi-asserted-by":"publisher","first-page":"550.e2","DOI":"10.1016\/j.cgh.2015.10.025","volume":"14","author":"B Ungar","year":"2016","unstructured":"Ungar B, Levy I, Yavne Y, et al. Optimizing anti-TNF-\u03b1 therapy: serum levels of infliximab and adalimumab are associated with mucosal healing in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2016;14:550.e2\u2013557.e2.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"5922_CR24","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1111\/apt.13970","volume":"45","author":"AJ Yarur","year":"2017","unstructured":"Yarur AJ, Kanagala V, Stein DJ, et al. Higher infliximab trough levels are associated with perianal fistula healing in patients with Crohn\u2019s disease. Aliment Pharmacol Ther. 2017;45:933\u2013940.","journal-title":"Aliment Pharmacol Ther"},{"key":"5922_CR25","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/ibd\/izy217","volume":"25","author":"W El-Matary","year":"2019","unstructured":"El-Matary W, Walters TD, Huynh HQ, et al. Higher postinduction infliximab serum trough levels are associated with healing of fistulizing perianal Crohn\u2019s disease in children. Inflamm Bowel Dis. 2019;25:150\u2013155.","journal-title":"Inflamm Bowel Dis"},{"key":"5922_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00384-017-2899-0","volume":"32","author":"SO Adegbola","year":"2017","unstructured":"Adegbola SO, Sahnan K, Tozer PJ, et al. Review of local injection of anti-TNF for perianal fistulising Crohn\u2019s disease. Int J Colorectal Dis. 2017;32:1539\u20131544.","journal-title":"Int J Colorectal Dis"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-019-05922-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-019-05922-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T09:01:46Z","timestamp":1664787706000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-019-05922-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,2]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["5922"],"URL":"https:\/\/doi.org\/10.1007\/s10620-019-05922-x","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,2]]},"assertion":[{"value":"2 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}